IFP Advisors, Inc - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 47 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2018. The put-call ratio across all filers is 3.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q4 2018$8,000
-42.9%
5,5000.0%0.00%
-100.0%
Q3 2018$14,000
-22.2%
5,5000.0%0.00%0.0%
Q2 2018$18,000
+1700.0%
5,500
+1150.0%
0.00%
Q3 2016$1,0000.0%4400.0%0.00%
Q2 2016$1,000
-50.0%
440
-18.5%
0.00%
Q4 2015$2,0005400.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2018
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 277,177$915,0000.11%
WEBSTER BANK, N. A. 50,000$165,0000.02%
Brown Advisory Securities, LLC 28,000$92,0000.02%
SIMPLEX TRADING, LLC 50,804$167,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$83,0000.00%
GROUP ONE TRADING, L.P. 89,372$295,0000.00%
Squarepoint Ops LLC 10,194$34,0000.00%
Tower Research Capital LLC (TRC) 1,851$6,0000.00%
WOLVERINE TRADING, LLC 58,500$193,0000.00%
WOLVERINE TRADING, LLC 61,690$204,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders